Skip to main content

Peer Review reports

From: A text-mining approach to study the real-world effectiveness and potentially fatal immune-related adverse events of PD-1 and PD-L1 inhibitors in older patients with stage III/IV non-small cell lung cancer

Original Submission
28 Sep 2022 Submitted Original manuscript
4 Dec 2022 Reviewed Reviewer Report
8 Dec 2022 Reviewed Reviewer Report
21 Jan 2023 Reviewed Reviewer Report - Jasvinder Singh
30 Jan 2023 Reviewed Reviewer Report
6 Feb 2023 Author responded Author comments - Hanieh Abedian Kalkhoran
Resubmission - Version 2
6 Feb 2023 Submitted Manuscript version 2
9 Feb 2023 Author responded Author comments - Hanieh Abedian Kalkhoran
Resubmission - Version 3
9 Feb 2023 Submitted Manuscript version 3
9 Feb 2023 Author responded Author comments - Hanieh Abedian Kalkhoran
Resubmission - Version 4
9 Feb 2023 Submitted Manuscript version 4
17 Feb 2023 Reviewed Reviewer Report
2 Mar 2023 Reviewed Reviewer Report - Jasvinder Singh
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
3 Mar 2023 Editorially accepted
14 Mar 2023 Article published 10.1186/s12885-023-10701-z

You can find further information about peer review here.

Back to article page